Bernard Esquivel MD,Ph.D., MAS
Vancouver,Canada
Summary
Visionary leader with over 15 years of experience driving growth, innovation, and operational excellence across health tech and biotech sectors. Known for leveraging AI-driven strategies, precision medicine expertise, and a deep understanding of regulatory frameworks to deliver groundbreaking solutions. Proven track record of scaling organizations, forging strategic partnerships, and achieving exponential revenue growth. Extensive network across the USA and globally in health tech and biotech, with a history of capital raising, strategic validation initiatives, and successful market entries.
Overview
14
14
years of professional experience
1
1
Certification
Work History
Chief Executive Officer
GenXys
01.2021 - Current
- Led the company’s strategic transformation from an academic-focused development organization to a profitable market leader in the SaaS space
- Achieved $1.3M ARR within 12 months, up from $330K, and projected $2.5M ARR in the next eight months by shifting to a scalable SaaS model
- Successfully raised capital by engaging with leading venture capital firms across North America, driving significant growth and expansion
- Developed and executed strategic channel partnerships, solidifying relationships with industry leaders and accelerating market penetration
- Fostered a culture of innovation and business-oriented thinking, aligning product development with market demands to enhance commercialization
- Built a global network in health tech and biotech to support business development and innovation initiatives
- Established foundational processes for business operations and scalable solutions.
- Negotiated favorable contracts with suppliers and vendors, ensuring cost-effective procurement processes.
- Identified new revenue generation opportunities to maximize bottom-line profitability.
- Streamlined operations for improved efficiency, reducing overall costs and increasing profitability.
- Drove continuous improvement by fostering a culture of collaboration, accountability, and open communication across all levels of the organization.
- Built productive relationships with industry partners like Thermo Fischer Scientific, Sophia Genetics, and competitors to support strategic business objectives.
- Directed research and development efforts in alignment with long-term strategic goals to maintain competitive advantage within the industry sector.
- Procured and coordinated new resources to achieve sales targets within optimal timeframes.
- Implemented strong financial controls, ensuring accurate reporting and solid decision-making capabilities.
- Guided mergers and acquisitions activities to expand corporate portfolio while achieving synergistic benefits from newly acquired entities.
- Established key strategic partnerships with industry leaders to enhance business development opportunities.
- Increased company revenue by implementing innovative business strategies and expanding product offerings.
Vice President of Clinical Innovation
Ixlayer
01.2022 - Current
- Directed strategic partnerships with CVS and Walgreens for nationwide at-home testing, achieving over $5M in revenue
- Secured a major partnership with LA Care, facilitating access to at-home testing for a vast patient population
- Expanded market footprint into Canada, forming a strategic alliance with the country’s largest clinical laboratory
- Developed AI-driven clinical workflows, achieving 3x growth in a year and integrating cutting-edge technology to optimize user experience
- Leveraged a strong network to validate initiatives with leading partners, enhancing Ixlayer’s global presence
- Cultivated strong relationships with key stakeholders, including customers, vendors, regulators, and community leaders to promote collaboration and long-term success.
- Led cross-functional teams for the successful completion of major projects, resulting in increased efficiency and client satisfaction.
- Developed new revenue streams by identifying growth opportunities and forging strategic partnerships with key industry players.
- Established a culture of continuous improvement, fostering innovation and driving sustainable growth across the organization.
- Leveraged technology to automate workflows and streamline processes, resulting in increased productivity and cost savings across the organization.
- Implemented advanced data analytics tools to drive data-driven decision-making across all levels of the organization, leading to better business outcomes.
- Launched new products or services in various markets by conducting comprehensive market research studies and tailoring offerings based on customer needs analysis.
Chief Medical Officer
OneOme (Mayo Clinic Subsidiary)
01.2018 - 01.2021
- Led international expansion efforts, achieving 42% revenue growth by establishing strategic partnerships
- Reorganized clinical operations to improve efficiency and ensure compliance, driving scalability
- Co-developed educational initiatives to increase adoption of pharmacogenomic solutions in clinical settings
- Created, educated, and mentored a Medical Affairs team with 7 MDs and PharmD.
- Improved patient outcomes and delivery of care through improved clinical quality processes.
- Drove planning for business development and relationship building with healthcare partners.
- Worked with research and pharmaceutical organizations to conduct clinical trials.
- Defined medical and administrative best practices in policies and procedures.
- Maintained compliance with local, national and federal requirements for staff education and certifications.
- Formulated risk management strategies to mitigate potential liabilities related to patient care, employee safety, and facility operations.
- Chaired committees responsible for evaluating new medical technologies assessing potential benefits limitations before adoption.
- Initiated collaborative research projects with academic institutions to advance knowledge in various medical specialties.
- Conducted financial management, marketing, and business oversight.
- Enhanced staff performance through comprehensive training programs, regular feedback, and performance evaluations.
Co-Founder & CEO
Genomedik SA de CV
01.2015 - 01.2019
- Pioneered a precision medicine clinic model, facilitating collaborations with Mayo Clinic and Miami University
- Created and implemented a strategic business model, leading to sustainable growth and profitable operations
- Evaluated market trends to identify emerging opportunities and inform strategic decision making.
- Conducted target market research to scope out industry competition and identify advantageous trends.
- Secured lucrative partnerships by establishing strong relationships with key industry players.
- Developed marketing materials and campaigns to boost brand awareness and customer engagement.
- Grew the customer base through targeted outreach and networking events.
- Established foundational processes for business operations.
- Developed key operational initiatives to drive and maintain substantial business growth.
- Provided strategic direction for product development, resulting in high-quality offerings that resonated with customers'' needs and preferences.
- Recruited, interviewed and hired new staff members and developed training materials for employees.
- Led a team of professionals to successfully launch new product lines, expanding the company''s market share.
- Drove company expansion into new markets, increasing overall brand visibility and recognition.
- Navigated complex legal requirements to ensure compliance with industry regulations while minimizing risk exposure for the business.
- Championed a culture of innovation, encouraging creative problem-solving throughout the organization.
- Enhanced investor relations and secured funding by delivering compelling presentations and detailed financial reports.
- Facilitated entry into international markets, adapting products to meet diverse customer needs.
- Secured partnership deals with key industry players, enhancing company market presence and brand recognition.
- Established new revenue streams by identifying market opportunities and launching innovative products or services.
- Led successful mergers and acquisitions, significantly increasing company's footprint and competitive edge.
Co-Founder & CEO
Total Quality Medicine
01.2011 - 01.2018
- Established LATAM’s largest genetic testing company, partnering with industry giants like Illumina and Sophia Genetics
- Managed 3,000-product portfolio, developing and licensing precision medicine technologies for B2B clients
- Successfully exited the company, selling to a strategic investment group, and created significant value for future growth.
- Evaluated market trends to identify emerging opportunities and inform strategic decision-making.
- Conducted target market research to scope out industry competition and identify advantageous trends.
- Streamlined product development cycles, accelerating time-to-market for new innovations.
- Strengthened financial health by effectively managing capital raises and budget allocations.
- Created succession plans to provide continuity of operations during leadership transitions.
- Maintained P&L and shouldered corporate fiscal responsibility.
- Established new revenue streams by identifying market opportunities and launching innovative products or services.
- Improved organizational structure by reallocating resources and redefining roles for greater efficiency.
- Spearheaded global expansion efforts, entering new markets and establishing profitable operations within two years.
- Represented organization at industry conferences and events.
Education
Doctor of Medicine -
PhD - Immunogenetics
Master in Administrative Science - Global Leadership
AI for Healthcare Specialization -
Skills
- Decision-Making
- Critical Thinking
- Complex Problem-Solving
- Client Relationship Building
- Strategic Planning
- Business Development
- Results-Driven
- Risk Management
- Organizational Leadership
- Executive Leadership
- Strategic Visioning
- Ethical Leadership
- Operating Budgets
- Operational Efficiency
- Public relations
Certification
- Innovation with AI in Healthcare, Harvard T.H. Chan School of Public Health
- Applied Artificial Intelligence for Healthcare, Harvard T.H. Chan School of Public Health
- Drug Development and FDA Approval Process, Harvard Medical School
- European Union In Vitro Diagnostic Regulation (IVDR), TUV SUD Academy
- Pharmacogenomics for Your Practice, Mayo Clinic
- Conflict Management at Work, Georgia Tech University
- Allergy and Clinical Immunology Certification, European Academy of Allergy and Clinical Immunology
Accomplishments
- Named Chief Medical Officer of the Year 2023 by MedHealth Outlook
- Featured in '40 Under 40' by New York Magazine
- Published three chapters in Pharmacogenomics in Clinical Practice, Springer Nature (2024)
Advisory Board Roles
- Board Member, Precision Medicine Advisors, USA
- Advisory Board Member, Genomii, Canada
- Chief Medical Consultant, Harrison Healthcare, Canada
- Active Member, American College of Medical Genetics & Genomics
- Editorial Board Member, National Institutes of Health (NIH) Clinical Genetics Guidelines
Industry Affiliations
- Founding Member, Pharmacogenomics Research Network (PGRN)
- Co-Chair, Global Genomic Medicine Collaborative
- Full Active Member, European Society of Human Genetics
- Guest Editor, International Journal of Molecular Sciences
Highlights
- $5M Revenue Growth, Led a nationwide at-home testing initiative with CVS and Walgreens, generating $M+ in revenue; in 12 months
- Capital Raising Success, Effectively engaged with top VCs across North America, securing funding to drive strategic initiatives.
- Revenue Scaling, Grew GenXys’s Annual Recurring Revenue (ARR) from $330K to $1.3M within 12 months, with a projected ARR of $2.5M in the next 8 months.
- Strategic Partnerships, Created and validated channel partnerships with marquee companies ( United Health Care Group, Oracle, Cencora, TFS, Illumina, Agena, Blue Cross Blue Shield, etc) expanding market reach and revenue potential.
- LATAM Market Pioneer, Founded and profitably exited Total Quality Medicine, LATAM’s largest genetic testing company.
Languages
English
Native or Bilingual
Spanish
Native or Bilingual
Named Chief Medical Officer of the Year 2023 by MedHealth Outlook & Featured in “40 Under 40” by New
• Chief Medical Officer of the Year 2023 – Awarded by MedHealth Outlook in recognition of outstanding leadership in healthcare innovation, strategic vision, and impact in advancing precision medicine and digital health technologies.
• Featured in “40 Under 40” – Highlighted by New York Magazine as one of the most influential and transformative leaders under 40, celebrated for driving advancements in pharmacogenomics, AI-driven health solutions, and regulatory expertise.
Timeline
Vice President of Clinical Innovation - Ixlayer
01.2022 - Current
Chief Executive Officer - GenXys
01.2021 - Current
Chief Medical Officer - OneOme (Mayo Clinic Subsidiary)
01.2018 - 01.2021
Co-Founder & CEO - Genomedik SA de CV
01.2015 - 01.2019
Co-Founder & CEO - Total Quality Medicine
01.2011 - 01.2018
National Polytechnic Institute - PhD, Immunogenetics
Fairleigh Dickinson University - Master in Administrative Science, Global Leadership
National Autonomous University of Mexico - Doctor of Medicine,
Harvard T.H. Chan School of Public Health - AI for Healthcare Specialization,
Similar Profiles
Philip Raymond LimPhilip Raymond Lim
Furniture Purchasing Director at Bella Virtual StagingFurniture Purchasing Director at Bella Virtual Staging
Panamvir BenipalPanamvir Benipal
Grocery Associate at WalmartGrocery Associate at Walmart
GENESIS TAKAGENESIS TAKA
Operations Manager at Andes Express S.A.COperations Manager at Andes Express S.A.C
Shivani JoshiShivani Joshi
IT Operations Analyst at RandstadIT Operations Analyst at Randstad
Kylie MillarKylie Millar
Executive Assistant to Chief Executive Officer, Vice President Corporate and Chief Risk Officer at Toyota Finance Australia LimitedExecutive Assistant to Chief Executive Officer, Vice President Corporate and Chief Risk Officer at Toyota Finance Australia Limited